Showing posts with label
institutional investors
.
Show all posts
Showing posts with label
institutional investors
.
Show all posts
Thursday, September 25, 2025
Today, I revisited BEAM Therapeutics and noted institutional investors increasing their positions! Here's the lowdown!
›
Quite a few funds besides Peregrine (17% this month) boosted their positions in BEAM Therapeutics in the last ~3 months. The biggest disc...
Friday, September 19, 2025
Cabaletta Bio $CABA might just be that "needle in the haystack" of Microcap BioTechs poised for greater things
›
Here’s a fresh, single-page style investment/business report on Cabaletta Bio (NASDAQ: CABA) that pulls in the August–September 2025 filing...
Wednesday, July 23, 2025
Why do Nvidia and so many institutional investors own most of the shares of RXRX - Recursion Pharma
›
Why Nvidia Invested in RXRX 1. Deep AI Integration for Drug Discovery In July 2023, Nvidia invested $50 million via a PIPE deal to he...
›
Home
View web version
